4//SEC Filing
Fisher Andrew 4
Accession 0001104659-25-060652
CIK 0001657312other
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 4:31 PM ET
Size
10.3 KB
Accession
0001104659-25-060652
Insider Transaction Report
Form 4
Fisher Andrew
General Counsel
Transactions
- Exercise/Conversion
Ordinary Shares
2025-06-16$2.01/sh+80,000$160,904→ 439,999 total - Exercise/Conversion
Share Options (Right to Buy)
2025-06-16−80,000→ 2,240,000 totalExercise: $2.01Exp: 2034-03-31→ Ordinary Shares (80,000 underlying) - Sale
Ordinary Shares
2025-06-16$11.53/sh−80,000$922,000→ 359,999 total
Footnotes (6)
- [F1]Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
- [F2]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into on January 15, 2025.
- [F3]The price reported represents a weighted average price of the ADSs divided by eight (8). The securities were sold in multiple transactions at prices ranging from $11.3994 to $11.7825 per Ordinary Share, inclusive (or $91.195 to $94.26 per ADS, inclusive). The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
- [F4]Consists of (i) 300,000 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 37,500 ADSs), (ii) 59,992 Ordinary Shares underlying 7,499 ADSs, and (iii) 7 Ordinary Shares.
- [F5]The number of securities underlying the option and the exercise price therefor are listed in terms of Ordinary Shares, however, each security is represented by American Depositary Shares, each of which represents eight (8) Ordinary Shares of the Issuer.
- [F6]The option vested and became exercisable as to 25% on March 4, 2025. The remainder of the shares vested or will vest in 36 equal monthly installments thereafter.
Documents
Issuer
Verona Pharma plc
CIK 0001657312
Entity typeother
Related Parties
1- filerCIK 0002014301
Filing Metadata
- Form type
- 4
- Filed
- Jun 17, 8:00 PM ET
- Accepted
- Jun 18, 4:31 PM ET
- Size
- 10.3 KB